Rentosertib
Chemical compound
Rentosertib is an investigational new drug that under evaluation for the treatment of idiopathic pulmonary fibrosis (IPF). It targets TNIK.
ATK 3373DEF 3384
Chemical compound
Rentosertib is an investigational new drug that under evaluation for the treatment of idiopathic pulmonary fibrosis (IPF). It targets TNIK.
Chemical compound
Nobody has pulled this card yet. The first copy makes you its discoverer.
Rentosertib is an investigational new drug that under evaluation for the treatment of idiopathic pulmonary fibrosis (IPF). It targets TNIK. It is asserted to be the first drug generated entirely by generative artificial intelligence to reach phase 3 human clinical trials, and the first to target a novel, AI-discovered biological pathway.
No sale yet.
None on the Market right now.